Healthcare Triangle, Inc. (Nasdaq: HCTI), a leader in digital transformation solutions for the healthcare and life sciences sectors, has announced a favorable decision from the Nasdaq Hearings Panel regarding the continued listing of its securities on the Nasdaq Stock Market. This decision comes after a review of a Public Interest Concern raised by Nasdaq’s Listing Qualifications Department, with the Panel concluding that the company meets the shareholders’ equity requirement and granting an exception to address prior deficiencies.

The Panel’s decision is contingent upon Healthcare Triangle, Inc. executing a reverse stock split by August 8, 2025, to comply with the Bid Price Rule, and demonstrating a closing bid price of at least $1 for twenty consecutive trading days by September 5, 2025. These steps are crucial for the company to maintain its listing and continue offering its securities to investors on the Nasdaq.

Dave Rosa, Chairman of the Board of Directors at HCTI, expressed gratitude for the Panel’s decision, highlighting the importance of the Nasdaq listing for the company’s investor base and its strategic growth plans. The company is focused on leveraging cloud technologies, AI-driven analytics, and secure data platforms to empower healthcare organizations, aiming for long-term sustainability and shareholder value enhancement.

Healthcare Triangle, Inc.’s commitment to compliance and its strategic initiatives underscore its dedication to innovation and leadership in the healthcare technology space. The company’s ability to meet Nasdaq’s requirements reflects its operational strengths and its potential for future growth in the evolving healthcare and life sciences industries.

This news story relied on content distributed by None. Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is Healthcare Triangle, Inc. Secures Continued Nasdaq Listing Amid Compliance Achievements.